{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:46:13Z","timestamp":1791297973277,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.cancergen.2012.01.009","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T19:47:54Z","timestamp":1332013674000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":178,"title":["Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background"],"prefix":"10.1016","volume":"205","author":[{"given":"Lauren","family":"Fishbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2012.01.009_bib1","article-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs","author":"DeLellis","year":"2004"},{"key":"10.1016\/j.cancergen.2012.01.009_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1196\/annals.1353.005","article-title":"Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge","volume":"1073","author":"Cohen","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cancergen.2012.01.009_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"Ayala-Ramirez","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib6","first-page":"1583","article-title":"Predictive factors for malignant pheochromocytoma: analysis of 136 patients","volume":"185","author":"Feng","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1442-2042.2007.01687.x","article-title":"Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute","volume":"14","author":"Huang","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12020-010-9422-5","article-title":"Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center","volume":"39","author":"Szalat","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.cancergen.2012.01.009_bib9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Mannelli","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib11","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-08-4057","article-title":"Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out","volume":"69","author":"Neumann","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/jc.2008-2756","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish patients","volume":"94","author":"Cascon","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib13","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas","volume":"94","author":"Burnichon","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0140-6736(91)90401-A","article-title":"Clustering of features and genetics of von Hippel-Lindau syndrome","volume":"338","author":"Neumann","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00268-005-0359-4","article-title":"Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center","volume":"30","author":"Delman","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.cancergen.2012.01.009_bib18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1210\/jc.2009-0354","article-title":"Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2","volume":"94","author":"Boedeker","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib19","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/jc.2009-1479","article-title":"Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome","volume":"94","author":"Gaal","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib20","unstructured":"Schimke RN, Collins DL, Stolle CA. Von Hippel-Lindau Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle, WA: University of Washington: 1993. (updated December 22, 2009). Available at http:\/\/www.genetests.org."},{"key":"10.1016\/j.cancergen.2012.01.009_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib22","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","article-title":"Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling","volume":"296","author":"Min","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.01.009_bib23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jmg.33.8.716","article-title":"Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A","volume":"33","author":"Chen","year":"1996","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004390050206","article-title":"Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe","volume":"98","author":"Glavac","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations","volume":"33","author":"Maher","year":"1996","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","article-title":"Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan","volume":"8","author":"Zbar","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.01.009_bib27","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1158\/0008-5472.CAN-11-0757","article-title":"VHL gene mutations and their effects on hypoxia inducible factor HIF{alpha}: identification of potential driver and passenger mutations","volume":"71","author":"Rechsteiner","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/prot.22419","article-title":"Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis","volume":"77","author":"Forman","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.cancergen.2012.01.009_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.01.009_bib30","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1210261","article-title":"Tumor microenvironment and neurofibromatosis type I: connecting the GAPs","volume":"26","author":"Le","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.01.009_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","article-title":"TORC1 is essential for NF1-associated malignancies","volume":"18","author":"Johannessen","year":"2008","journal-title":"Curr Biol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib32","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2012.01.009_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib34","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib35","first-page":"659","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.cancergen.2012.01.009_bib37","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma","volume":"354","author":"Bausch","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2010.02.001","article-title":"Multiple endocrine neoplasia type 2","volume":"24","author":"Wohllk","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2012.01.009_bib40","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.cancergen.2012.01.009_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1998.3751208.x","article-title":"Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma","volume":"48","author":"Pomares","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cancergen.2012.01.009_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2796.2004.01425.x","article-title":"Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour","volume":"257","author":"Pacak","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1995.tb01211.x","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group","volume":"238","author":"Modigliani","year":"1995","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib45","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(00)04378-6","article-title":"Germline SDHD mutation in familial phaeochromocytoma","volume":"357","author":"Astuti","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.01.009_bib47","first-page":"6822","article-title":"Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma","volume":"60","author":"Gimm","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0005-2728(99)00071-7","article-title":"Characterization of the human SDHD gene encoding the small subunit of cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase","volume":"1412","author":"Hirawake","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergen.2012.01.009_bib49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000134700","article-title":"Cytochrome b in human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning of the components in liver mitochondria and chromosome assignment of the genes for the large (SDHC) and small (SDHD) subunits to 1q21 and 11q23","volume":"79","author":"Hirawake","year":"1997","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":"Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD","volume":"31","author":"Ricketts","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2012.01.009_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gcc.1142","article-title":"Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss","volume":"31","author":"Badenhop","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib52","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1136\/jmg.2003.012658","article-title":"Genetic and epigenetic profile of sporadic pheochromocytomas","volume":"41","author":"Cascon","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1507\/endocrj.K09E-111","article-title":"Predominant expression of mutated allele of the succunate dehydrogenase D (SDHD) gene in the SDHD-related paragangliomas","volume":"56","author":"Yamashita","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.cancergen.2012.01.009_bib54","doi-asserted-by":"crossref","first-page":"e7987","DOI":"10.1371\/journal.pone.0007987","article-title":"Sdhd and SDHD\/H19 knockout mice do not develop paraganglioma or pheochromocytoma","volume":"4","author":"Bayley","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cancergen.2012.01.009_bib55","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1210\/jc.2007-1989","article-title":"Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation","volume":"93","author":"Pigny","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib56","doi-asserted-by":"crossref","first-page":"E2009","DOI":"10.1210\/jc.2011-1244","article-title":"Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect","volume":"96","author":"Yeap","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib57","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2012.01.009_bib58","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1200\/JCO.2005.07.198","article-title":"Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD","volume":"23","author":"Dannenberg","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","author":"Hao","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.01.009_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","author":"Bayley","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1078-0432.CCR-10-0420","article-title":"SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma","volume":"17","author":"Kunst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-1119(98)00186-3","article-title":"Characterization of the human SDHC gene encoding of the integral membrane proteins of succinate-quinone oxidoreductase in mitochondria","volume":"213","author":"Elbehti-Green","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.cancergen.2012.01.009_bib63","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1136\/jmg.2003.011551","article-title":"The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features","volume":"41","author":"Badenhop","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jmg.39.3.178","article-title":"Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas","volume":"39","author":"Baysal","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10689-004-0621-1","article-title":"SDHC mutations in hereditary paraganglioma\/pheochromocytoma","volume":"4","author":"Muller","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib66","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.294.16.2057","article-title":"Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene","volume":"294","author":"Schiavi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2012.01.009_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ncpendmet0726","article-title":"Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation","volume":"4","author":"Peczkowska","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib69","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1210\/jc.2002-020525","article-title":"Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma","volume":"87","author":"Gimenez-Roqueplo","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib70","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib71","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2006-0920","article-title":"Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations","volume":"91","author":"Pollard","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib72","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/MCB.01338-07","article-title":"Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis","volume":"28","author":"Guzy","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","article-title":"SDH mutations in tumorigenesis and\u00a0inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes","volume":"266","author":"Pasini","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib74","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2008.03274.x","article-title":"Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers","volume":"69","author":"Srirangalingam","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cancergen.2012.01.009_bib76","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.otohns.2007.01.015","article-title":"Malignant head and neck paragangliomas in SDHB mutation carriers","volume":"137","author":"Boedeker","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.cancergen.2012.01.009_bib78","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib79","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.01.009_bib80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/modpathol.2010.185","article-title":"SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors","volume":"24","author":"Gaal","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib81","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0b013e3181d6150d","article-title":"Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types","volume":"34","author":"Gill","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib83","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.01.009_bib84","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2012.01.009_bib85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jmg.2004.028829","article-title":"Cancer risks in BRCA2 families: estimates for sites other than breast and ovary","volume":"42","author":"van Asperen","year":"2005","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib86","unstructured":"Howlader N, Noone AM, Krapcho M, et\u00a0al. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute. Available at: http:\/\/seer.cancer.gov\/csr\/1975-2008\/. Based on Nov 2010 SEER data submission, posted to the SEER website in 2011."},{"key":"10.1016\/j.cancergen.2012.01.009_bib87","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMc071191","article-title":"Familial gastrointestinal stromal tumors and germ-line mutations","volume":"357","author":"McWhinney","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.ejhg.5201904","article-title":"Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD","volume":"16","author":"Pasini","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib89","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1445-2197.2006.03855.x","article-title":"Gastrointestinal stromal tumour in succinate dehydrogenase subunit B mutation-associated familial phaeochromocytoma\/paraganglioma","volume":"76","author":"Bolland","year":"2006","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.cancergen.2012.01.009_bib90","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2009.02110.x","article-title":"The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications","volume":"266","author":"Stratakis","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib91","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.2005.067041","article-title":"Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA)","volume":"77","author":"Horvath","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cancergen.2012.01.009_bib92","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ejhg.2010.83","article-title":"Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase","volume":"18","author":"Levitas","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s004399900218","article-title":"Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome","volume":"106","author":"Parfait","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib94","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib95","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","author":"Qin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib97","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1001\/jama.2010.1830","article-title":"Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas","volume":"304","author":"Yao","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2012.01.009_bib98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-10-0758","article-title":"A\u00a0novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma","volume":"164","author":"Burnichon","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib99","doi-asserted-by":"crossref","first-page":"E1279","DOI":"10.1210\/jc.2011-0114","article-title":"Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites","volume":"96","author":"Neumann","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-Mendez","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib101","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.2006410","article-title":"Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc","volume":"251","author":"Blackwood","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2012.01.009_bib102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","article-title":"The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer","volume":"39","author":"Chen","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.cancergen.2012.01.009_bib103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2008-1073156","article-title":"Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas","volume":"40","author":"Eisenhofer","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib104","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11906-010-0151-1","article-title":"Genetic testing for pheochromocytoma","volume":"12","author":"Karasek","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.cancergen.2012.01.009_bib105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.cancergen.2012.01.009_bib106","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib107","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib108","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.HYP.36.6.1045","article-title":"Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment","volume":"36","author":"Rao","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.cancergen.2012.01.009_bib109","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","author":"Eisenhofer","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00467-008-1111-8","article-title":"Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?","volume":"24","author":"Prodanov","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib111","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMc070010","article-title":"Somatic SDHB mutation in an extraadrenal pheochromocytoma","volume":"357","author":"van Nederveen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2012.01.009_bib112","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2012.01.009_bib113","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ijc.11060","article-title":"Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas","volume":"105","author":"Dannenberg","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/00313020400024816","article-title":"Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET","volume":"37","author":"Cho","year":"2005","journal-title":"Pathology"},{"key":"10.1016\/j.cancergen.2012.01.009_bib115","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2826.2008.01755.x","article-title":"Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas","volume":"20","author":"Hrascan","year":"2008","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib116","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1507\/endocrj.42.517","article-title":"Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma","volume":"42","author":"Kimura","year":"1995","journal-title":"Endocr J"},{"key":"10.1016\/j.cancergen.2012.01.009_bib117","first-page":"922","article-title":"Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing","volume":"145","author":"Komminoth","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib118","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<537::AID-IJC16>3.0.CO;2-Z","article-title":"Prognostic value of RET proto-\\oncogene point mutations in malignant and benign, sporadic phaeochromocytomas","volume":"79","author":"van der Harst","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib119","first-page":"1596","article-title":"Low-frequency of Ras gene-mutations in neuroblastomas, pheochromocytomas, and medullary-thyroid cancers","volume":"51","author":"Moley","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib120","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1349-7006.1992.tb02722.x","article-title":"ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism","volume":"83","author":"Yoshimoto","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib121","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/1097-0142(19930815)72:4<1386::AID-CNCR2820720439>3.0.CO;2-J","article-title":"Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis","volume":"72","author":"Yoshimoto","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib122","first-page":"1702","article-title":"G\u00a0protein gene mutations in patients with multiple endocrinopathies","volume":"80","author":"Williamson","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib123","first-page":"483","article-title":"Mutations of the p53 gene in human functional adrenal neoplasms","volume":"78","author":"Lin","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/105221608786883825","article-title":"Expression of the p16INK4A\/Cdkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens","volume":"14","author":"Muscarella","year":"2008","journal-title":"Gene Expr"},{"key":"10.1016\/j.cancergen.2012.01.009_bib125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1677\/ERC-07-0285","article-title":"Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas","volume":"15","author":"Kiss","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib126","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1078-0432.CCR-07-1867","article-title":"Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior","volume":"14","author":"Geli","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib127","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1196\/annals.1353.037","article-title":"Analysis of PTEN mutation in non-familial pheochromocytoma","volume":"1073","author":"Puc","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cancergen.2012.01.009_bib128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/path.1968","article-title":"PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas","volume":"209","author":"van Nederveen","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/path.2492","article-title":"Conditional Pten knock-out mice: a model for metastatic phaeochromocytoma","volume":"217","author":"Korpershoek","year":"2009","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/gcc.20139","article-title":"A\u00a0novel candidate region linked to development of both pheochromocytoma and head\/neck paraganglioma","volume":"42","author":"Cascon","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib131","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9440(10)64769-4","article-title":"Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology","volume":"156","author":"Edstrom","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergen.2012.01.009_bib132","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.onc.1205149","article-title":"Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome","volume":"21","author":"Lui","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2012.01.009_bib133","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ijc.21385","article-title":"Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH","volume":"118","author":"Jarbo","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib134","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1677\/ERC-08-0241","article-title":"Array-comparative genomic hybridization in sporadic benign pheochromocytomas","volume":"16","author":"van Nederveen","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.cancergen.2012.01.009_bib135","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1158\/0008-5472.CAN-05-1427","article-title":"Novel pheochromocytoma susceptibility loci identified by integrative genomics","volume":"65","author":"Dahia","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2012.01.009_bib136","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1210\/jc.2007-1253","article-title":"Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy","volume":"92","author":"Thouennon","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cancergen.2012.01.009_bib137","first-page":"2382","article-title":"Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","author":"Lopez-Jimenez","year":"2010","journal-title":"Mol l"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776212000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:36:45Z","timestamp":1761896205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776212000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":137,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S2210776212000385"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.01.009","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2012.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}